ArticleHuman vaccines & immunotherapeutics2018
Progress toward a group B streptococcal vaccine.
Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- Pooled it
- Article
- Virulence and pathogenicity of group BVirulence · 2025Review
- Genomic characterization of group BMicrobial genomics · 2025Article
- Immune responses against group BiScience · 2023Article
- Calibration of a serum reference standard for Group B streptococcal polysaccharide conjugate vaccine development using surface plasmon resonance.NPJ vaccines · 2023Article
- Group B Streptococcus: Virulence Factors and Pathogenic Mechanism.Microorganisms · 2022Review
- Serotype Distribution, Virulence Determinants and Antimicrobial Susceptibility of Streptococcus agalactiae Isolated from Young InfantsPathogens (Basel, Switzerland) · 2022Article
- Identifying large-scale recombination and capsular switching events inMicrobial genomics · 2022Article
- Defeating meningitis by 2030 - an ambitious target.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2021Article
- Molecular Characteristics of ISmSphere · 2021Article
- Development and Validation of Enzyme-Linked Immunosorbent Assay for Group B Streptococcal Polysaccharide Vaccine.Vaccines · 2021Article
- A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents:Microorganisms · 2021Review
- Determination of Capsular Serotypes, Antibiotic Susceptibility Pattern, and Molecular Mechanism of Erythromycin Resistance among Clinical Isolates of Group BAdvanced biomedical research · 2021Article
- Asymptomatic GBS bacteriuria during antenatal visits: To treat or not to treat?The Nurse practitioner · 2020Article
- Age-stratified analysis of serotype-specific baseline immunity against group B streptococcus.Human vaccines & immunotherapeutics · 2020Article
- Prevalence and capsular type distribution of group BIranian journal of microbiology · 2020Article
- Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement.Frontiers in immunology · 2020Review
- The 100 top-cited studies on vaccine: a bibliometric analysis.Human vaccines & immunotherapeutics · 2019Article
- An increasing trend of neonatal invasive multidrug-resistant group B streptococcus infections in southern China, 2011-2017.Infection and drug resistance · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.